Systemic lupus erythematosus (SLE) is an autoimmune disease with protean manifestations
that predominantly affects young women. Certain ethnic groups are more vulnerable than …

While systemic lupus erythematosus (SLE) is an autoantibody and immune complex disease
by nature, most of its organ manifestations are in fact inflammatory. SLE activity scores thus …

Objective To assess mortality rates (MRs), standardized mortality ratios, and causes of death
in systemic lupus erythematosus (SLE) in a population-based study. Methods We analyzed …

Purpose of review To describe root causes of health disparities by reviewing studies on
incidence and outcomes of systemic lupus erythematosus (SLE) related to ethnic, race …

Introduction Systemic lupus erythematosus (SLE) is an autoimmune disorder that affects
almost every organ system and it is treated with immunomodulation and …

Systemic lupus erythematosus (SLE) is a prototypic systemic autoimmune disease that
develops in genetically susceptible individuals in response to environmental factors. SLE …

Rationale & Objective Belimumab improved kidney outcomes in patients with active lupus
nephritis (LN) in BLISS-LN, leading to its approval in the United States and the European …

Background Pediatric lupus nephritis (pLN) is one of the most refractory secondary kidney
diseases in childhood. The treat-to-target (T2T) strategy has become the standard treatment …

Abstract Systemic Lupus Erythematosus is a systemic autoimmune disease characterized by
a great heterogenicity in course and clinical manifestations. Although prognosis improved in …

Given the self-evident importance of cutaneous immunity in the maintenance of body-
surface homeostasis, disturbance of the steady-state skin is inextricably intertwined with …